• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过优化五个关键因素提高大肠杆菌中胰岛素样生长因子I蛋白的产量。

Enhanced Production of Insulin-like Growth Factor I Protein in Escherichia coli by Optimization of Five Key Factors.

作者信息

Ranjbari Javad, Babaeipour Valiollah, Vahidi Hossein, Moghimi Hamidreza, Mofid Mohammad Reza, Namvaran Mohammad Mehdi, Jafari Sevda

机构信息

Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ; Department of Life Science Engineering, School of New Science and Technologies, University of Tehran, Iran.

出版信息

Iran J Pharm Res. 2015 Summer;14(3):907-17.

PMID:26330880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4518120/
Abstract

Human insulin-like growth factor I (hIGF-I) is a kind of growth factor with clinical significance in medicine. Up to now, E. coli expression system has been widely used as a host to produce rhIGF-1 with high yields. Batch cultures as non-continuous fermentations were carried out to overproduce rhIGF-I in E. coli. The major objective of this study is over- production of recombinant human insulin-like growth factor I (rhIGF-I) through a developed process by recruiting effective factors in order to achieve the most recombinant protein. In this study we investigated the effect of culture medium, induction temperature and amount of inducer on cell growth and IGF-1 production. Taguchi design of experiments (DOE) method was used as the statistical method. Analysis of experimental data showed that maximum production of rhIGF-I was occurred in 32y culture medium at 32 °C and 0.05 Mm IPTG. Under this condition, 0.694 g/L of rhIGF-I was produced as the inclusion bodies. Following optimization of these three factors, we have also optimized the amount of glucose and induction time in 5 liter top bench bioreactor. Full factorial design of experiment method was used for these two factors as the statistical method. 10 g/L and OD600=5 were selected as the optimum point of Glucose amount and induction time, respectively. Finally, we reached to a concentration of 1.26 g/L rhIGF-1 at optimum condition.

摘要

人胰岛素样生长因子I(hIGF-I)是一种在医学上具有临床意义的生长因子。到目前为止,大肠杆菌表达系统已被广泛用作宿主来高产重组人胰岛素样生长因子-1(rhIGF-1)。进行分批培养作为非连续发酵,以在大肠杆菌中过量生产rhIGF-I。本研究的主要目的是通过开发一种方法,通过引入有效因素来过量生产重组人胰岛素样生长因子I(rhIGF-I),以获得最多的重组蛋白。在本研究中,我们研究了培养基、诱导温度和诱导剂用量对细胞生长和IGF-1产量的影响。采用田口实验设计(DOE)方法作为统计方法。实验数据分析表明,rhIGF-I的最大产量出现在32Y培养基中,温度为32°C,IPTG浓度为0.05 mM时。在此条件下,以包涵体形式产生了0.694 g/L的rhIGF-I。在优化这三个因素之后,我们还在5升台式生物反应器中优化了葡萄糖用量和诱导时间。对这两个因素采用全因子实验设计方法作为统计方法。分别选择10 g/L和OD600 = 5作为葡萄糖用量和诱导时间的最佳点。最后,在最佳条件下我们得到了1.26 g/L的rhIGF-1浓度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dec/4518120/988858835861/ijpr-14-907-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dec/4518120/05e219b354da/ijpr-14-907-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dec/4518120/1dc90e29f5c3/ijpr-14-907-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dec/4518120/89138e9f95f5/ijpr-14-907-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dec/4518120/4c006ed96624/ijpr-14-907-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dec/4518120/2a3542549ae1/ijpr-14-907-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dec/4518120/06e6ade23915/ijpr-14-907-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dec/4518120/988858835861/ijpr-14-907-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dec/4518120/05e219b354da/ijpr-14-907-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dec/4518120/1dc90e29f5c3/ijpr-14-907-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dec/4518120/89138e9f95f5/ijpr-14-907-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dec/4518120/4c006ed96624/ijpr-14-907-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dec/4518120/2a3542549ae1/ijpr-14-907-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dec/4518120/06e6ade23915/ijpr-14-907-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dec/4518120/988858835861/ijpr-14-907-g007.jpg

相似文献

1
Enhanced Production of Insulin-like Growth Factor I Protein in Escherichia coli by Optimization of Five Key Factors.通过优化五个关键因素提高大肠杆菌中胰岛素样生长因子I蛋白的产量。
Iran J Pharm Res. 2015 Summer;14(3):907-17.
2
Effect of Acyl Homoserine Lactone on Recombinant Production of Human Insulin-like Growth Factor-1 in Batch Culture of Escherichia coli.酰基高丝氨酸内酯对大肠杆菌分批培养中重组人胰岛素样生长因子-1生产的影响
Protein Pept Lett. 2018;25(11):980-985. doi: 10.2174/0929866525666181019150657.
3
Lab-scale Preparation of Recombinant Human Insulin-like Growth Factor-1 in and its Potential Safety on Normal Human Lung Cell Line.实验室规模制备重组人生长因子-1 及其对正常人体肺细胞系的潜在安全性。
Recent Pat Biotechnol. 2022 Aug 3;16(3):266-280. doi: 10.2174/1872208316666220412105822.
4
Efficient process development for high-level production, purification, formulation, and characterization of recombinant mecasermin in Escherichia coli.高效开发生产工艺,在大肠杆菌中高表达、纯化、制剂及鉴定重组人生长激素。
Biotechnol Appl Biochem. 2021 Aug;68(4):776-788. doi: 10.1002/bab.1990. Epub 2020 Aug 7.
5
Enhanced production of human mini-proinsulin in fed-batch cultures at high cell density of Escherichia coli BL21(DE3)[pET-3aT2M2].在大肠杆菌BL21(DE3)[pET - 3aT2M2]高细胞密度补料分批培养中提高人迷你胰岛素原的产量。
Biotechnol Prog. 1997 May-Jun;13(3):249-57. doi: 10.1021/bp970018m.
6
Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.美卡舍明林非巴肽:胰岛素样生长因子-I/胰岛素样生长因子结合蛋白-3,美卡舍明林非巴肽,重组人胰岛素样生长因子-I/重组人胰岛素样生长因子结合蛋白-3
Drugs R D. 2005;6(2):120-7. doi: 10.2165/00126839-200506020-00008.
7
Expression of Recombinant Human Insulin-like Growth Factor Type 1 (rhIGF-1) in Escherichia coli.重组人胰岛素样生长因子1(rhIGF-1)在大肠杆菌中的表达。
Avicenna J Med Biotechnol. 2015 Jul-Sep;7(3):101-5.
8
Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome.重组人胰岛素样生长因子I(rhIGF-I)/重组人胰岛素样生长因子结合蛋白-3复合物用于生长激素不敏感综合征患者的药代动力学研究。
J Clin Endocrinol Metab. 2006 Apr;91(4):1246-53. doi: 10.1210/jc.2005-1017. Epub 2006 Jan 10.
9
Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment.重组人胰岛素样生长因子-I(rhIGF-I)对1型糖尿病成年患者的治疗:对胰岛素样生长因子、胰岛素样生长因子结合蛋白、血糖水平及胰岛素治疗的影响
Clin Endocrinol (Oxf). 1998 Dec;49(6):739-46. doi: 10.1046/j.1365-2265.1998.00600.x.
10
Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.重组人胰岛素样生长因子I(IGF-I)治疗对一名部分IGF-I基因缺失患者生长激素-IGF系统的影响。
J Clin Endocrinol Metab. 1999 May;84(5):1611-6. doi: 10.1210/jcem.84.5.5649.

引用本文的文献

1
Comparing the Soluble Form of Recombinant Human Insulin-like Growth Factor-1 (rhIGF-1) in Using Thioredoxin as Fused and Co-expressed Protein.比较使用硫氧还蛋白作为融合和共表达蛋白的重组人胰岛素样生长因子-1(rhIGF-1)的可溶性形式。
Protein Pept Lett. 2024;31(6):469-478. doi: 10.2174/0109298665314267240624091046.
2
Review Insights In Cardiac Tissue Engineering: Cells, Scaffolds, and Pharmacological Agents.心脏组织工程学综述:细胞、支架与药理剂
Iran J Pharm Res. 2021 Fall;20(4):467-496. doi: 10.22037/IJPR.2021.114730.15012.
3
Acetate Kinase a Antisense Delivery by PAMAM Dendrimer for Decreasing Acetate Production and Increasing the Production of Recombinant Albumin in .

本文引用的文献

1
Anticarcinogenic effect of quercetin by inhibition of insulin-like growth factor (IGF)-1 signaling in mouse skin cancer.槲皮素通过抑制胰岛素样生长因子(IGF)-1 信号通路对小鼠皮肤癌的抗癌作用。
Nutr Res Pract. 2013 Dec;7(6):439-45. doi: 10.4162/nrp.2013.7.6.439. Epub 2013 Nov 29.
2
Maximizing Production of Human Interferon-γ in HCDC of Recombinant E. coli.在重组大肠杆菌高密度细胞培养中最大化人干扰素-γ的产量
Iran J Pharm Res. 2013 Summer;12(3):563-72.
3
Application of Taguchi Design and Response Surface Methodology for Improving Conversion of Isoeugenol into Vanillin by Resting Cells of Psychrobacter sp. CSW4.
通过聚酰胺-胺型树枝状大分子递送醋酸激酶a反义核酸以减少醋酸生成并增加重组白蛋白产量
Iran J Biotechnol. 2021 Jan 1;19(1):e2617. doi: 10.30498/IJB.2021.2617. eCollection 2021 Jan.
4
Optimization of Key Factors in Serum Free Medium for Production of Human Recombinant GM-CSF Using Response Surface Methodology.利用响应面法优化无血清培养基中生产人重组粒细胞-巨噬细胞集落刺激因子的关键因素
Iran J Pharm Res. 2019 Fall;18(Suppl1):146-156. doi: 10.22037/ijpr.2020.112322.13681.
5
Optimization and One-Step Purification of Recombinant V Antigen Production from Yersinia pestis.从鼠疫耶尔森氏菌中优化和一步纯化重组 V 抗原的生产。
Mol Biotechnol. 2020 Mar;62(3):177-184. doi: 10.1007/s12033-019-00234-x.
6
Optimization of Growth Conditions of Mycelium and Polysaccharides on Walnut Shell by-Products Using Response Surface Analysis.基于响应面分析的核桃壳副产物菌丝体和多糖生长条件优化
Iran J Pharm Res. 2018 Fall;17(4):1509-1522.
7
Effect of Culture Condition Variables on Human Endostatin Gene Expression in Using Response Surface Methodology.应用响应面法研究培养条件变量对人内皮抑素基因表达的影响。
Jundishapur J Microbiol. 2016 May 8;9(8):e34091. doi: 10.5812/jjm.34091. eCollection 2016 Aug.
8
Expression and Secretion of Endostar Protein by Escherichia Coli: Optimization of Culture Conditions Using the Response Surface Methodology.大肠杆菌表达及分泌内皮抑素蛋白:采用响应面法优化培养条件
Mol Biotechnol. 2016 Oct;58(10):634-647. doi: 10.1007/s12033-016-9963-9.
9
The effect of cell disruption techniques and chaotropic agents on the downstream purification process of mecasermin produced as inclusion body in E. coli.细胞破碎技术和离液剂对在大肠杆菌中作为包涵体产生的美卡舍明下游纯化过程的影响。
Res Pharm Sci. 2015 Nov-Dec;10(6):553-61.
田口设计法和响应面法在提高嗜冷杆菌属CSW4静息细胞将异丁香酚转化为香草醛转化率中的应用
Iran J Pharm Res. 2013 Summer;12(3):411-21.
4
Strategies for the production of recombinant protein in Escherichia coli.大肠杆菌中重组蛋白的生产策略。
Protein J. 2013 Aug;32(6):419-25. doi: 10.1007/s10930-013-9502-5.
5
In plant activation: an inducible, hyperexpression platform for recombinant protein production in plants.在植物激活中:一种诱导型、超表达平台,用于植物中重组蛋白的生产。
Plant Cell. 2013 Jul;25(7):2429-43. doi: 10.1105/tpc.113.113944. Epub 2013 Jul 9.
6
Recombinant protein production: a comparative view on host physiology (Laupheim, Germany, March 2013).
N Biotechnol. 2013 Jun 25;30(5):405-9. doi: 10.1016/j.nbt.2013.06.002. Epub 2013 Jun 14.
7
Optimizing heterologous protein production in the periplasm of E. coli by regulating gene expression levels.通过调控基因表达水平优化大肠杆菌周质腔中异源蛋白的生产。
Microb Cell Fact. 2013 Mar 12;12:24. doi: 10.1186/1475-2859-12-24.
8
The insulin-like growth factor mutation database (IGFmdb).胰岛素样生长因子突变数据库(IGFmdb)。
Growth Horm IGF Res. 2012 Oct;22(5):158-66. doi: 10.1016/j.ghir.2012.05.001. Epub 2012 Jun 13.
9
Foreign protein production using plant cells: opportunities and challenges.利用植物细胞生产外源蛋白:机遇与挑战。
Biotechnol Adv. 2012 Mar-Apr;30(2):385-6. doi: 10.1016/j.biotechadv.2011.08.002. Epub 2011 Aug 10.
10
Growth hormone and adrenal response to intramuscular glucagon test and its relationship to IGF-1 production and left ventricular ejection fraction in adult B-thalassemia major patients.成年重型β地中海贫血患者生长激素和肾上腺对肌肉注射胰高血糖素试验的反应及其与胰岛素样生长因子-1生成和左心室射血分数的关系。
Pediatr Endocrinol Rev. 2011 Mar;8 Suppl 2:290-4.